AFT upgrades guidance following maiden US sale

AFT upgrades guidance following maiden US sale
Managing director Hartley Atkinson says he's confident AFT's investments will reward shareholders over the medium to long term. (Image: Supplied)
John Anthony
Dual-listed pharmaceutical company AFT Pharmaceuticals has lifted its profit guidance for the year to March following the first sale of its intravenous pain-relief medicine in the United States.AFT expects operating profit to range between $23 million and $25m, up on earlier guidance of $22m to $24m.US successIn a statement to the Australian securities exchange (ASX) and New Zealand stock exchange (NZX) on Friday morning, AFT said the update followed a review of January trading and news that Hikma Pharmaceuticals, the US licensee of its pain-re...

More Markets

The Warehouse is 'cooked', everyone knows it
Opinion

Simon Robertson: The Warehouse is 'cooked', everyone knows it

Retail is hard because you need to live and breathe it.

NZ stocks end firmly as outlook brightens
Markets Market Close

NZ stocks end firmly as outlook brightens

Improved, post-results season sentiment drove NZ stocks higher.

Jamie Gray 28 Nov 2025
The Warehouse Albany and Silverdale could be first in line for store revamp
Retail

The Warehouse Albany and Silverdale could be first in line for store revamp

The Warehouse’s Albany and Silverdale stores could be first in line to undergo an interior revamp, according to chief executive Mark Stirton, who gave an update to shareholders at the company’s annual meeting on Friday.The meeting covered everything from the company’s 2025 financ...

Staff reporters 28 Nov 2025
Westpac cops $3.64m penalty for lender responsibility breaches
Finance

Westpac cops $3.64m penalty for lender responsibility breaches

Credit Contracts and Consumer Finance Act in focus again.

Andy Macdonald 28 Nov 2025